logo
Lord Kinnock's £2bn VAT raid would crush the NHS

Lord Kinnock's £2bn VAT raid would crush the NHS

Telegraph4 days ago
Every now and then, the ghost of a politician past makes an appearance, as if to carry out the public service of reminding us that terrible leaders aren't a blight unique to our generation.
Last week, Lord Kinnock urged the Chancellor to launch a VAT raid on private healthcare. The former Labour leader claimed the policy would raise £2bn in 'vital funding for the NHS and social care'.
He said that 'many people are turning to private healthcare, not out of choice, but because they cannot afford to wait'.
Many people are indeed turning to private healthcare, Lord Kinnock is right about that. He also correctly identifies the reason behind this being the long waiting lists, which have now become a permanent feature of the NHS.
But, remarkably, he arrives at a diagnosis which would considerably worsen the situation.
It was reported last year that almost half of 18- to 24-year-olds are opting to pay for a GP appointment in order to beat the waiting list on the NHS, with the total number of people going private to see a GP approaching four million.
There has also been a 30pc increase in the number of people paying privately for hospital care across the UK, according to data released by the Nuffield Trust.
This is happening, we are told, despite record levels of staffing and greater levels of funding within the NHS.
In June, the Government entered an agreement with the independent healthcare sector as part of its plans to end the hospital waiting list backlog.
Some of the statistics released at that time bring home the scale of the crisis in the NHS from across departments – in gynaecology, there is a backlog of 260,000 women waiting more than 18 weeks for treatment, while in orthopaedics, 40pc of patients were waiting longer than the 18-week target.
All these figures point to an NHS that is failing to cope with the nation's healthcare demands, and is relying on the private sector to lend a helping hand both at the general and specialist care levels.
How on earth, then, would slapping VAT on private healthcare help the struggling NHS? It would make it more expensive and price out many of its current customers, as at least some of those people would return to the NHS's burgeoning waiting lists.
Every taxpayer who takes themself out of the NHS and into the private medical market already pays twice for the service. Once through their tax bill, and once through their private medical bill or insurance.
On top of that, there is insurance premium tax to be paid on private healthcare, which last year brought in over £2bn for HM Revenue and Customs.
Questions have also been raised around the veracity of the £2bn carrot which Lord Kinnock is dangling in front of the Chancellor as he pushes his VAT policy. For that amount to be raised, the tax would have to be levied on the use of private opticians and dentists, the latter being a service which the NHS is notorious for failing to provide.
Tax expert, Dan Neidle, has suggested that the policy might in fact lose the Treasury money. It is businesses which pay for most private healthcare in this country, through providers such as Bupa, which currently do not charge VAT, nor do they recover their own VAT costs.
But with the exemption scrapped, explains Neidle, businesses would be able to claim back the VAT on the provision of private healthcare, and providers could in turn reclaim their own VAT costs from the Treasury.
People who ease the pressure on the perpetually ailing NHS by paying for private medical care out of their pockets should be incentivised to carry on doing so through tax deductions – not punished by higher taxes.
And any VAT raid would backfire on the entire population by worsening the pressure on the state-owned healthcare system.
Desperate as Rachel Reeves is for revenue-raising ideas, if she doesn't want her legacy to be the destruction of the NHS then she must stay clear of yet another disastrous VAT blunder.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Boy with fragile skin disorder given hope after new treatment
Boy with fragile skin disorder given hope after new treatment

The Independent

time15 minutes ago

  • The Independent

Boy with fragile skin disorder given hope after new treatment

A boy with a rare skin condition which can cause damage with even the smallest amount of friction has been given hope after taking part in a trial for the first potential treatment for the genetic disorder. Gabrielius Misurenkovas, 12, from east London, was diagnosed with an inflammatory disease called recessive dystrophic epidermolysis bullosa (RDEB) when he was a baby. Many symptoms of the painful condition have been alleviated thanks to a new trial in which he received certain stem cells via an intravenous drip. The rare genetic disease is severely debilitating. People with the condition have extremely fragile skin which is easily damaged, leading to blistering, deep wounds and scarring. About 150 children in the UK are affected by RDEB, which is painful and causes itchiness. With no disease-modifying treatment available, patients and their families manage symptoms by dressing wounds and applying eye ointments. Over time, the condition can lead to severe complications and many patients with the condition develop a type of skin cancer called squamous cell carcinoma when they are young adults – this is the most common cause of death for RDEB patients. Gabrielius has been under the care of medics at the world-renowned children's hospital Great Ormond Street (GOSH) since he was a baby. He said he jumped at the chance to join the clinical trial when it was suggested by his doctors. 'I wanted to take part in the trial as I was excited to see if it could help improve my condition and so I could do more of the things I enjoy, like playing football and spending time with my friends,' he said. The youngster, who can speak three languages and is a big fan of footballer Lionel Messi, needed his bandages changing three times a day, or more if he was injured. His mother, Jolita Cekaviciene, said: 'Gabrielius did really well on the trial. 'His wounds healed quicker, and his skin was less red and inflamed. 'His skin was also less itchy which also reduced him scratching. 'His sleep was also less disturbed as he didn't need to have his special wound dressings changed as often, so this was a great benefit.' She said Gabrielius has managed to do a few things that he was not able to before the treatment, including taking part in some sports at school, riding his bike in the park on the grass, and being able to play football with his friends, with a soft ball. Ms Cekaviciene said the trial has given her son more freedom than before, but he still needs to be careful in any activity to avoid falling over or bumps. Gabrielius was referred to GOSH as a baby after medics spotted a wound when he was born, and he was diagnosed with RDEB when he was two weeks old. Ms Cekaviciene said: 'The first two years were really hard as you had to watch him constantly – even rubbing his eyes could cause painful blistering. 'He couldn't even tell us how much pain he was in or where he was hurting.' RDEB is a genetic condition which is caused by a fault in the gene that makes a protein which holds layers of skin together – collagen VII. Medics wanted to assess whether regular infusions with mesenchymal stromal cells (MSC) improved symptoms for children with the condition, after studies suggested that MSC treatments could promote wound healing, reduce inflammation and stimulate tissue regeneration. In the trial, funded by NHS England, the National Institute for Health and Care Research and the charity Cure EB, children were given a treatment called CORDStrom, manufactured by INmuneBio. Gabrielius is one of 30 children who took part in the new clinical trial at GOSH and Birmingham Children's Hospital. Patients would go into hospital and have a drip which delivers the cells over 10 to 15 minutes. In the study patients were split into two groups, about half were given the treatment, which is made from umbilical cord tissue, as an infusion, twice over two weeks. The other half were given a placebo, also known as a dummy drug. They then had a nine-month gap, known as a wash-out period, where the group that were initially given the dummy drug were given the treatment, while the group that received therapy first were given a dummy drug. The study, published in the journal eClinicalMedicine, reported a positive outcome of the treatment. The largest effects were in children under the age of 10, and in the children with intermediate type of RDEB. Families involved in the study reported a positive impact on daily life and well-being, with a reduction in both pain and itching. The treatment was said to be well tolerated by the children. INmuneBio have agreed to provide CORDStrom free of charge for a year for all children who took part in the trial, so researchers can continue to study them, and patients are expected to get two infusions of the treatment every four months. The company is seeking regulatory approval for the treatment so it can be approved for use in the UK and other countries. Chief investigator of the study, Dr Anna Martinez, paediatric dermatologist at GOSH, said: 'Our study has demonstrated that CORDStrom was safe and can help reduce disease activity in some patients with RDEB. 'Administering the treatment early and at regular intervals appears to reduce itch and improve wound healing, which over time we hope will reduce inflammation, modify the condition and may reduce over time the future risk of squamous cell carcinoma. 'It's fantastic to see how the patients, like Gabrielius, had improvements in their symptoms and their quality of life.' She added: 'The 12-month open label study will allow us to collect more data to hopefully show an increased benefit from treatments administered in children and young people with RDEB, to continue research in support of the treatment being rolled out more widely.' Sharmila Collins, founder trustee of Cure EB, said: 'Since funding the first trial and by contributing to Mission EB we have been working towards bringing MSC infusions forward for all children in the UK with RDEB. 'We hope these cells will become part of routine clinical care to alleviate the significant suffering of children with this condition.'

Government turns to TikTok to highlight risks of cosmetic surgery abroad
Government turns to TikTok to highlight risks of cosmetic surgery abroad

The Herald Scotland

timean hour ago

  • The Herald Scotland

Government turns to TikTok to highlight risks of cosmetic surgery abroad

As part of the initiative, the Government will work with medical influencers, such as Midwife Marley and Doc Tally, to create videos showing the risks of cosmetic surgery abroad. The content will urge patients to speak to a UK doctor first and avoid package holidays that include procedures. It will also include a checklist for patients to consider before they book a procedure, which includes checking the credentials of surgeons, the clinic's regulations, and understanding the aftercare. The initiative is part of a wider Government drive to tackle so-called medical tourism and ensure the NHS is not left to foot the bill when complications arise. Health minister Karin Smyth said: 'Too many people are being left with life-altering injuries after going abroad for medical procedures, without access to proper advice or safeguards. 'Often drawn in by deals too good to be true and promoted by influencers – some of whom have never been to the practice in question. 'By partnering with TikTok, we're helping people make safer, more informed choices before they go under the knife – wherever that may be.' Foreign Office minister Stephen Doughty said: 'Our aim is to explain the risks and help British people understand the actions they can take to keep themselves safe when abroad. 'If you choose to travel abroad for medical treatment, it is vital you do your research and are fully aware of the risks involved. 'We urge anyone considering a medical procedure abroad to review our travel advice, relevant guidance from the NHS and other professional bodies, and research foreign providers thoroughly to ensure they meet the highest standard of care. 'Informed choices today can help avoid serious complications tomorrow.' The initiative comes after ministers outlined plans to cut down on 'cowboy' cosmetic procedures by introducing new restrictions. Earlier this month, the Department of Health and Social Care unveiled proposals which include only allowing 'suitably qualified' and Care Quality Commission-regulated health workers to deliver high-risk procedures such as Brazilian butt lifts. Elsewhere, clinics offering Botox and fillers will need licences, and age restrictions will be introduced to prevent children from trying to follow 'dangerous beauty trends on social media'. Those who break the rules will face sanctions, including financial penalties, officials said.

Government turns to TikTok to highlight risks of cosmetic surgery abroad
Government turns to TikTok to highlight risks of cosmetic surgery abroad

ITV News

timean hour ago

  • ITV News

Government turns to TikTok to highlight risks of cosmetic surgery abroad

The Government will use social media influencers to highlight the risks of travelling abroad for cosmetic procedures such as hair transplants and dental work under new plans. Ministers hope the new campaign with TikTok will help people make 'more informed choices before they go under the knife'. As part of the initiative, the Government will work with medical influencers, such as Midwife Marley and Doc Tally, to create videos showing the risks of cosmetic surgery abroad. The content will urge patients to speak to a UK doctor first and avoid package holidays that include procedures. It will also include a checklist for patients to consider before they book a procedure, which includes checking the credentials of surgeons, the clinic's regulations, and understanding the aftercare. The initiative is part of a wider Government drive to tackle so-called medical tourism and ensure the NHS is not left to foot the bill when complications arise. Health minister Karin Smyth said: 'Too many people are being left with life-altering injuries after going abroad for medical procedures, without access to proper advice or safeguards. 'Often drawn in by deals too good to be true and promoted by influencers – some of whom have never been to the practice in question. 'By partnering with TikTok, we're helping people make safer, more informed choices before they go under the knife – wherever that may be.' Foreign Office minister Stephen Doughty said: 'Our aim is to explain the risks and help British people understand the actions they can take to keep themselves safe when abroad. 'If you choose to travel abroad for medical treatment, it is vital you do your research and are fully aware of the risks involved. 'We urge anyone considering a medical procedure abroad to review our travel advice, relevant guidance from the NHS and other professional bodies, and research foreign providers thoroughly to ensure they meet the highest standard of care. 'Informed choices today can help avoid serious complications tomorrow.' The initiative comes after ministers outlined plans to cut down on 'cowboy' cosmetic procedures by introducing new restrictions. Earlier this month, the Department of Health and Social Care unveiled proposals which include only allowing 'suitably qualified' and Care Quality Commission-regulated health workers to deliver high-risk procedures such as Brazilian butt lifts. Elsewhere, clinics offering Botox and fillers will need licences, and age restrictions will be introduced to prevent children from trying to follow 'dangerous beauty trends on social media'. Those who break the rules will face sanctions, including financial penalties, officials said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store